Serotonergic blunting to meta-chlorophenylpiperazine (m-CPP) highly correlates with sustained childhood abuse in impulsive and autoaggressive female borderline patients

Biological Psychiatry

Volumn 47, Issue 6, 1999, Pages 548-556

  Rinne, Thomas ^a   Westenberg, Herman G M ^b   Den Boer, Johan A ^c   Van Den Brink, Wim ^d  

^a Geestgronden Inst Mental Hlth Care   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Borderline personality disorder; Childhood abuse trauma; Cortisol; m chlorophenylpiperazine (m CPP); Prolactin; Serotonin (5 HT)

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; CORTICOSTERONE; HYDROCORTISONE; PROLACTIN; SEROTONIN 1A RECEPTOR;

ADULT; AGGRESSION; ALCOHOLISM; ARTICLE; BEHAVIOR; BORDERLINE STATE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG ABUSE; FEMALE; HUMAN; IMPULSIVENESS; INJURY; PRIORITY JOURNAL; PROVOCATION TEST; SEROTONINERGIC SYSTEM; SEXUAL ABUSE; STRESS;

ADOLESCENT; ADULT; BORDERLINE PERSONALITY DISORDER; CHILD; CHILD ABUSE; CHILD, PRESCHOOL; FEMALE; HUMANS; HYDROCORTISONE; IMPULSIVE BEHAVIOR; MIDDLE AGED; PIPERAZINES; PROLACTIN; PSYCHIATRIC STATUS RATING SCALES; SELF-INJURIOUS BEHAVIOR; SEROTONIN; SEROTONIN AGONISTS; SEVERITY OF ILLNESS INDEX; STRESS DISORDERS, POST-TRAUMATIC;

EID: 0342546034     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00181-X     Document Type: Article

References (55)

1. Anand A., Charney D.S., Delgado P.L., McDougle C.J., Heninger G.R., Price L.H. Neuroendocrine and behavioral responses to intravenous mCPP in depressed patients and healthy comparison subjects. Am J Psychiatry. 151:1994;1626-1630.
2. Arrindell W.A., Ettema H. Dimensionele strutuur, betrouwbaaarheid en validiteit van de Nederlandse bewerking van de Symptom Checklist (SCL-90); gegevens gebaseerd op een fobische en 'normale' populatie. Ned Tijdschr Psychol. 36:1981;77-108.
3. Asberg M., Traskman L., Thoren P. 5-HIAA in the cerebrospinal fluid. Arch Gen Psychiatry. 33:1976;1193-1197.
4. Bagdy G. Role of the hypothalamic paraventricular nucleus in 5-HT1A, 5-HT2A and 5-HT2C receptor-mediated oxytocin, prolactin and ACTH/corticosterone responses. Behav Brain Res. 73:1996;277-280.
5. 1 agonists in the rat. Neuroendocrinology. 50:1989;241-247.
6. Barratt E.S. Factor analysis of some psychometric measures of impulsiveness and anxiety. Psychol Rep. 16:1965;547-554.
7. Barratt ES (1985): Impulsiveness subtraits: Arousal and information processing. In: Spencer JT, Izard CE, editors. Motivation, Emotion, and Personality. Amsterdam: Elsevier Science, 137-146.
8. Barratt ES, Patton J (n.d.): Barratt Impulsiveness Scale version 11 (BIS 11). Galveston, TX: University of Texas, Medical Branch, Department of Psychiatry and Behavioral Sciences.
9. Buss A.H., Durkee A. An inventory for assessing different kinds of hostility. J Consult Clin Psychol. 21:1957;343-349.
10. 2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP). Eur J Pharmacol. 257:1994;27-38.
11. Cleare A.J., Murray R.M., O'Keane V. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects. Neuropsychopharmacology. 14:1996;349-354.
12. Coccaro E.F., Siever L.J., Klar H.M., Maurer G. Serotonergic studies in patients with affective and personality disorders. Arch Gen Psychiatry. 46:1989;587-599.
13. Cowen PJ (1993): Serotonin receptor subtypes in depression: Evidence from studies in neuroendocrine regulation. Clin Neuropharmacol 16:S6-S18.
14. Dehghani B., Lange A. Validatie van de nederlandse versie van de Buss-Durkee Hostility Inventory. Gedr Gezond. 21:1993;298-303.
15. Derogatis L.R., Lipman R.S., Covi L. SCL-90 An outpatient rating scale - preliminary report . Psychopharmacol Bull. 9:1973;13-27.
16. Draijer N. Structured Trauma Interview. 1989;Department of Psychiatry, Vrije Universiteit, Amsterdam.
17. 2Creceptors in the stimulus effects of m-chlorophenylpiperazine. Psychopharmacology (Berlin). 119:1995;222-230.
18. Goldman S.J., D'Angelo E.J., DeMaso D.R., Mezzacappa E. Physical and sexual abuse histories among children with borderline personality disorder. Am J Psychiatry. 149:1992;1723-1726.
19. Hamik A., Peroutka S.J. 1-(m-Chlorophenyl) piperazine (mCPP) interactions with neurotransmitter receptors in the human brain. Biol Psychiatry. 25:1989;569-575.
20. Hamilton M. Rating depressive patients. J Clin Psychiatry. 41:1980;21-24.
21. Henninger GR, Charney DS, Prince L, Delgado PL, Woods SW, Goodman W (1990): Neuroendocrine effects of serotonin agonists in rhesus monkeys, healthy humans and patients with depression or anxiety disorders: Effects of anti-depressant treatment. In: Vanhoutte PM, Paoletti R, editors. Serotonin: From Cell Biology to Pharmacology and Therapeutics. Dordrecht, The Netherlands: Kluwer Academic, 559-563.
22. Herman J.L., Perry J.C., van der Kolk B. Childhood trauma in borderline personality disorder. Am J Psychiatry. 146:1989;490-495.
23. Herpertz S., Steinmeyer S.M., Marx D., Oidtmann A., Sass H. The significance of aggression and impulsivity for self-mutilative behavior. Pharmacopsychiat. 28:1995;64-72.
24. Hollander E., Stein D.J., DeCaria C.M., Cohen L., Saoud J.B. Serotonergic sensitivity in borderline personality disoder Preliminary findings . Am J Psychiatry. 151:1994;277-280.
25. Kahn R.S., Wetzler S., Asnis G.M., Papolos D., van Praag H.M. Serotonin receptor sensitivity in major depression. Biol Psychiatry. 28:1990;358-362.
26. Kaufman J., Birmaher B., Perel J., Dahl R., Stull S., Brent D.A., Trubnick L., AL-Shabbout M., Ryan N. Serotonergic function in depressed abused children Clinical and familial correlates . Biol Psychiatry. 44:1998;973-981.
27. Landecker H. The role of childhood sexual trauma in the etiologiy of borderline personality disorder Considerations for diagnosis and treatment . Psychotherapy. 29:1992;234-242.
28. Lange A, Hoogendoorn M, Wiederspahn A, de Beuris E (1995): BDHI-Dutch, Buss-Durkee Hostility Inventory, 1st ed. Lisse, The Netherlands: Swets en Zeitlinger B.V.
29. Lemieux A.M., Coe C.L. Abuse-related posttraumatic stress disorder evidence for chronic neuroendocrine activation in women . Psychosom Med. 57:1995;105-115.
30. Linnoila M., Virkkunen M. Aggression, suicidality, and serotonin. J Clin Psychiatry. 53:1992;46-51.
31. Marital J., Paris J., Leyton M., Zweig-Frank H., Schwartz G., Teboul E., Thavundayil J., Larue S., Ng Ying Kin N.M.K., Vasavan Nair N.P. Neuroendocrine study of serotonin function in female borderline patients A pilot study . Biol Psychiatry. 42:1997;737-739.
32. 1A receptor mRNA in Rat Dentate Gyrus. Eur J Pharmacol. 266:1994;255-261.
33. Meltzer H.Y., Maes M. Pindolol pretreatment blocks stimulation by meta-chlorophenylpiperazine of prolactin but not cortisol secretion in normal men. Psychiatry Res. 58:1995;89-98.
34. 1B receptors in the dorsal hippocampus and cortex of the rat. Neuroendocrinology. 55:1992;444-450.
35. Ogata S.N., Silk K.R., Goodrich S., Lohr N.E., Westen D., Hill E.M. Childhood sexual and physical abuse in adult patients with borderline personality disoreder. Am J Psychiatry. 147:1990;1008-1013.
36. O'Keane V., Dinan T.G. Prolactin and cortisol responses to d-fenfluramine in major depression Evidence for diminished responsivity of central serotonergic function . Am J Psychiatry. 148:1991;1009-1015.
37. O'Keane V., McLoughlin D., Dinan T.G. D-fenfluramine-induced prolactin and cortisol release in major depression. J Affect Disord. 26:1992;143-150.
38. O'Keane V., Moloney E., O'Neill H., O'Connor A., Smith C., Dinan T.G. Blunted prolactin responses to d-Fenfluramine in sociopathy evidence for subsensitivity of central serotonergic function. Br J Psychiatry. 160:1992;643-646.
39. O'Keane V., O'Hanlon M., Webb M., Dinan T. d-fenfluramine/prolactin response throughout the menstrual cycle Evidence for an oestrogen-induced alteration . Clin Endocrinol. 34:1991;289-292.
40. Park S.B.G., Cowen P.J. Effects of pindolol on the prolactin response to d-fenfluramine. Psychopharmacology (Berlin). 118:1995;471-474.
41. Perry JC, Herman JL (1993): Trauma and defense in the etiology of borderline personality disorder. In: Paris J, editor. Borderline Personality Disorder, 1st ed. Montreal: American Psychiatric Press, Inc., 123-140.
42. Peters D.A.V. Prenatal stress effects on development of rat brain serotonergic neurons . Pharmacol Biochem Behav. 24:1986;1377-1382.
43. Pfohl B., Blum N., Zimmerman M., Stangl D. SIDP-R Structured Interview for DSM III-R Personality Disorders. 1989;University of Iowa, Iowa City, IA.
44. Pine D., Coplan J., Wasserman G., Miller L., Fried J., Davis M., Cooper T., Greenhill L., Shaffer D., Parsons B. Neuroendocrine response to fenfluramine challenge in boys, associations with aggressive behavior and adverse rearing. Arch Gen Psychiatry. 54:1997;839-846.
45. Rosenblum L.A., Coplan J.D., Friedman S., Bassoff T., Gorman J.M., Andrews M.W. Adverse early experiences affect noradrenergic and serotonergic functioning in adult primates. Biol Psychiatry. 35:1994;221-227.
46. Salzman J.P., Salzman C., Wolfson A.N., Albanese A., Looper J., Ostacher M., Schwartz J., Chinman G., Land W., Miyawaki E. Assossiation between borderline personality structure and history of childhood abuse in adult volunteers. Compr Psychiatry. 34:1993;254-257.
47. Shearer S.L., Peters C.P., Quaytman M.S., Ogden R.L. Frequency and correlates of childhood sexual and physical abuse histories in adult female borderline inpatients. Am J Psychiatry. 147:1990;214-216.
48. Siever L.J., Murphy D.L., Slater S., Vega Edl, Lipper S. Plasma prolactin changes following fenfluramine in depressed patients compared to controls an avaluation of central serotonergic responsivity in depression . Life Sci. 34:1984;1029-1039.
49. Siever L.J., Trestman R.L. The serotonin system and aggressive personality. Int Clin Psychopharmacol. 8:1993;33-39.
50. Silk K.R., Lee S., Hill E.M., Lohr N.E. Borderline personality disorder symptoms and severity of sexual abuse. Am J Psychiatry. 152:1995;1059-1064.
51. Spitzer R.L., Williams J.B., Gibbon M., First M.B. The Structured Clinical Interview for DSM-III-R (SCID). I History, rationale, and description . Arch Gen Psychiatry. 49:1992;624-629.
52. Stein D.J., Hollander E., DeCaria C.M., Simeon D., Cohen L., Aronowitz B. M-CCP challenge in borderline personality disorder Relationship of neuroendocrine response, behavioral resonse, and clinical measures . Biol Psychiatry. 40:1996;508-513.
53. Suckow R.F., Cooper T.B., Kahn R.S. High-performance liquid chromatographic method for the analysis of plasma m-chlorophenylpiperazine. J Chromatogr. 528:1990;228-234.
54. van den Brink W, de Jong C (1992): Gestructureerd Interview voor de DSM-III-R Persoonlijkheidsstoornissen/ Pfohl B, Blum N, Zimmerman M, Stangl D. IVB-Reeks nr.2, Eindhoven, The Netherlands: Instituut voor Verslavingsonderzock Brabant.
55. Wagner A.W., Linehan M.M. Relationship between childhood sexual abuse and topography of parasuicide among women with borderline personality disorder. J Pers Disord. 8:1994;1-9.